Shanghai, China

Liling Jin

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: Liling Jin: Innovator in Pharmaceutical Chemistry

Introduction

Liling Jin is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on tromethamine salts. His research has implications for improving drug solubility and bioavailability.

Latest Patents

Liling Jin holds a patent for an invention titled "Amorphous asiatic tromethamine salt and preparation method thereof." This patent describes a method that includes several steps: dissolving asiatic acid in an organic solvent, mixing it with tromethamine, stirring, salifying the mixture, and subsequently removing the organic solvent. The resulting amorphous asiatic tromethamine salt exhibits enhanced water solubility and bioavailability compared to prior art, making it a valuable advancement in pharmaceutical formulations. He has 1 patent to his name.

Career Highlights

Liling Jin is affiliated with the Shanghai Institute of Pharmaceutical Industry, where he conducts his research and development activities. His work is characterized by a focus on practical applications that can lead to improved therapeutic outcomes.

Collaborations

Liling Jin collaborates with several esteemed colleagues, including Guobin Ren and Ying Liu. Their combined expertise fosters a productive research environment that encourages innovation and the development of new pharmaceutical solutions.

Conclusion

Liling Jin's contributions to pharmaceutical chemistry, particularly through his patented methods, highlight his role as an innovator in the field. His work not only advances scientific knowledge but also has the potential to improve patient care through enhanced drug formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…